CLINICAL RESEARCH: HEART FAILURE
Relationship Between Renal Function and Plasma Brain Natriuretic Peptide in Patients With Heart Failure
Takayoshi Tsutamoto, MD*,
Atsuyuki Wada, MD,
Hiroshi Sakai, MD,
Chitose Ishikawa, MD,
Toshinari Tanaka, MD,
Masaru Hayashi, MD,
Masanori Fujii, MD,
Takashi Yamamoto, MD,
Tomohiro Dohke, MD,
Masato Ohnishi, MD,
Hiroyuki Takashima, MD,
Masahiko Kinoshita, MD and
Minoru Horie, MD
Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan
Manuscript received June 5, 2005;
revised manuscript received October 5, 2005,
accepted October 10, 2005.
* Reprint requests and correspondence: Dr. Takayoshi Tsutamoto, Cardiovascular and Respiratory Medicine, Shiga University of Medical Science Tsukinowa, Seta, Otsu 520-2192, Japan (Email: tutamoto{at}belle.shiga-med.ac.jp).
OBJECTIVES: This study sought to evaluate the relationship between brain natriuretic peptide (BNP), renal function, and the severity of congestive heart failure (CHF).
BACKGROUND: Both BNP and renal function are prognostic predictors in CHF patients.
METHODS: We measured the plasma BNP level in the aortic root and coronary sinus in 366 consecutive patients with CHF. Estimated glomerular filtration rate (eGFR) by the Cockcroft-Gault equation was used as an indicator of renal function.
RESULTS: By stepwise multivariate analyses, hemodynamic parameters such as left ventricular ejection fraction (LVEF) and left ventricular end-diastolic pressure (LVEDP) but not eGFR were independent predictors of a transcardiac increase (coronary sinus-aortic root) in BNP. Regarding the plasma level of BNP in the aortic root, not only LVEF (p < 0.0001) and LVEDP (p < 0.0001) but also eGFR (p < 0.0001) were independent predictors. Patients were divided into two groups, patients with an eGFR 60 ml/min (group 1, n = 229) and patients with an eGFR <60 ml/min (group 2, n = 137). There was no difference in LVEF, LVEDP, or the transcardiac gradient of BNP between the two groups, but the plasma level of BNP in the aortic root was approximately two-fold greater in group 2 than in the group 1.
CONCLUSIONS: These findings suggest that decreased clearance from the kidney contributes to the elevated BNP in CHF patients with renal dysfunction, especially in patients with an eGFR <60 ml/min.
|
Abbreviations and Acronyms
| | BNP = brain natriuretic peptide | | CHF = congestive heart failure | | CKD = chronic kidney disease | | eGFR = estimated glomerular filtration rate | | GFR = glomerular filtration rate | | LVEDP = left ventricular end-diastolic pressure | | LVEF = left ventricular ejection fraction |
|
This article has been cited by other articles:

|
 |

|
 |
 
F. Macheret, G. Boerrigter, P. McKie, L. Costello-Boerrigter, B. Lahr, D. Heublein, S. Sandberg, Y. Ikeda, A. Cataliotti, K. Bailey, et al.
Pro-B-Type Natriuretic Peptide1-108 Circulates in the General Community: Plasma Determinants and Detection of Left Ventricular Dysfunction
J. Am. Coll. Cardiol.,
March 22, 2011;
57(12):
1386 - 1395.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. S. Maisel, N. Katz, H. L. Hillege, A. Shaw, P. Zanco, R. Bellomo, I. Anand, S. D. Anker, N. Aspromonte, S. M. Bagshaw, et al.
Biomarkers in kidney and heart disease
Nephrol. Dial. Transplant.,
January 1, 2011;
26(1):
62 - 74.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. T. Maeder, J. A. Mariani, and D. M. Kaye
Hemodynamic Determinants of Myocardial B-Type Natriuretic Peptide Release: Relative Contributions of Systolic and Diastolic Wall Stress
Hypertension,
October 1, 2010;
56(4):
682 - 689.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Fragopoulou, D. B. Panagiotakos, C. Pitsavos, C. Chrysohoou, T. Nomikos, A. Evangelopoulos, C. Katsagoni, J. Skoumas, S. Antonopoulou, and C. Stefanadis
N-Terminal ProBNP Distribution and Correlations With Biological Characteristics in Apparently Healthy Greek Population: ATTICA Study
Angiology,
May 1, 2010;
61(4):
397 - 404.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
R. K. Rogers, J. Stehlik, G. J. Stoddard, T. Greene, S. P. Collins, W. F. Peacock, A. D. Maisel, P. Clopton, and A. D. Michaels
Adjusting for clinical covariates improves the ability of B-type natriuretic peptide to distinguish cardiac from non-cardiac dyspnoea: a sub-study of HEARD-IT
Eur J Heart Fail,
November 1, 2009;
11(11):
1043 - 1049.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Choquet, C. Cavalcanti-Proenca, C. Lecoeur, C. Dina, S. Cauchi, M. Vaxillaire, S. Hadjadj, F. Horber, N. Potoczna, G. Charpentier, et al.
The T-381C SNP in BNP gene may be modestly associated with type 2 diabetes: an updated meta-analysis in 49 279 subjects
Hum. Mol. Genet.,
July 1, 2009;
18(13):
2495 - 2501.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Tsutamoto, C. Kawahara, M. Yamaji, K. Nishiyama, M. Fujii, T. Yamamoto, and M. Horie
Relationship between renal function and serum cardiac troponin T in patients with chronic heart failure
Eur J Heart Fail,
July 1, 2009;
11(7):
653 - 658.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Santos-Araujo, R. Roncon-Albuquerque Jr, M. Moreira-Rodrigues, T. Henriques-Coelho, J. Quelhas-Santos, B. Faria, B. Sampaio-Maia, A. F. Leite-Moreira, and M. Pestana
Local modulation of the natriuretic peptide system in the rat remnant kidney
Nephrol. Dial. Transplant.,
June 1, 2009;
24(6):
1774 - 1782.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Tsutamoto, K. Nishiyama, H. Sakai, T. Tanaka, M. Fujii, T. Yamamoto, M. Yamaji, and M. Horie
Transcardiac increase in norepinephrine and prognosis in patients with chronic heart failure
Eur J Heart Fail,
December 1, 2008;
10(12):
1208 - 1214.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Tagore, L. H. Ling, H. Yang, H.-Y. Daw, Y.-H. Chan, and S. K. Sethi
Natriuretic Peptides in Chronic Kidney Disease
Clin. J. Am. Soc. Nephrol.,
November 1, 2008;
3(6):
1644 - 1651.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Lancellotti, B. Cosyns, and L. A. Pierard
Dynamic left ventricular dyssynchrony contributes to B-type natriuretic peptide release during exercise in patients with systolic heart failure
Europace,
April 1, 2008;
10(4):
496 - 501.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. B. Daniels and A. S. Maisel
Natriuretic Peptides
J. Am. Coll. Cardiol.,
December 18, 2007;
50(25):
2357 - 2368.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. J. Paulus, C. Tschope, J. E. Sanderson, C. Rusconi, F. A. Flachskampf, F. E. Rademakers, P. Marino, O. A. Smiseth, G. De Keulenaer, A. F. Leite-Moreira, et al.
How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology
Eur. Heart J.,
October 2, 2007;
28(20):
2539 - 2550.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Hogenhuis, A. A. Voors, T. Jaarsma, A. W. Hoes, H. L. Hillege, J. A. Kragten, and D. J. van Veldhuisen
Anaemia and renal dysfunction are independently associated with BNP and NT-proBNP levels in patients with heart failure
Eur J Heart Fail,
August 1, 2007;
9(8):
787 - 794.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Tsutamoto, T. Tanaka, H. Sakai, C. Ishikawa, M. Fujii, T. Yamamoto, and M. Horie
Total and high molecular weight adiponectin, haemodynamics, and mortality in patients with chronic heart failure
Eur. Heart J.,
July 2, 2007;
28(14):
1723 - 1730.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Shadman, M. A. Allison, and M. H. Criqui
Glomerular Filtration Rate and N-Terminal Pro-Brain Natriuretic Peptide as Predictors of Cardiovascular Mortality in Vascular Patients
J. Am. Coll. Cardiol.,
June 5, 2007;
49(22):
2172 - 2181.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Tsutamoto, H. Sakai, C. Ishikawa, M. Fujii, T. Tanaka, T. Yamamoto, H. Takashima, M. Ohnishi, A. Wada, and M. Horie
Direct comparison of transcardiac difference between brain natriuretic peptide (BNP) and N-terminal pro-BNP in patients with chronic heart failure
Eur J Heart Fail,
June 1, 2007;
9(6-7):
667 - 673.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. N. DeMaria, O. Ben-Yehuda, G. K. Feld, G. S. Ginsburg, B. H. Greenberg, W. Y.W. Lew, J. A.C. Lima, A. S. Maisel, J. Narula, D. J. Sahn, et al.
Highlights of the Year in JACC 2006
J. Am. Coll. Cardiol.,
January 30, 2007;
49(4):
509 - 527.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Masson, R. Latini, I. S. Anand, T. Vago, L. Angelici, S. Barlera, E. D. Missov, A. Clerico, G. Tognoni, J. N. Cohn, et al.
Direct Comparison of B-Type Natriuretic Peptide (BNP) and Amino-Terminal proBNP in a Large Population of Patients with Chronic and Symptomatic Heart Failure: The Valsartan Heart Failure (Val-HeFT) Data
Clin. Chem.,
August 1, 2006;
52(8):
1528 - 1538.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|